HIT Consultant – Read More
What You Should Know
- Medication access and financial assistance technology leader TailorMed announced that it has secured a majority private equity investment from New York-based GrowthCurve Capital.
- GrowthCurve Capital focuses on accelerating middle-market technology enterprises by operationalizing artificial intelligence, product engineering, and unlocking proprietary datasets.
- The transaction positions TailorMed to scale its AI-enabled software portfolio and expand distribution across hospital health systems, ambulatory clinics, retail and specialty pharmacies, and life sciences manufacturers.
- The investment addresses high financial toxicity and therapy drop-off, particularly for complex oncology, rare disease, and chronic specialty cohorts where expensive out-of-pocket costs drive prescription abandonment.
The Architecture of Medication Success: Scaling Network Effects
Founded in 2016 by Srulik Dvorsky and Adam Siton following personal family battles with serious illness, TailorMed evolved from a niche financial navigation software into a unified medication access operating system.
The platform’s defensibility stems from its multi-sided network density, which bridges clinical EHR charting, pharmacy dispensing queues, and manufacturer affordability programs:
- Enterprise Provider & Pharmacy Network: Integrated directly into clinical and pharmacy management workflows across more than 950 hospitals, 4,700 outpatient clinics, and 3,100 pharmacies nationwide.
- Massive Capital Recovery Volume: TailorMed’s resource engine maps into more than 6,000 public and private assistance programs and over 100 life sciences patient support initiatives. Since 2020, the platform has supported over 75 million patients and unlocked more than $7.4 billion in financial assistance.
- Unified Product Portfolio: The operating footprint spans five synchronized layers:
- TailorMed Core: Identifies at-risk patients early in the clinical encounter by analyzing EHR demographics, insurance benefits, and treatment regimens to predict out-of-pocket exposure.
- TailorMed Connect & Complete: Automates the enrollment and documentation matching process for foundation grants, co-pay assistance, government subsidies, and free drug programs.
- TailorMed Amplify & Alliance: Bridges provider health systems and pharmaceutical manufacturers, creating transparent, auditable channels for life sciences brands to route copay cards and patient support services directly into EHR-integrated workflows without intermediary friction.
Srulik Dvorsky, CEO and Co-Founder of TailorMed, framed the growth transition: “When we founded TailorMed, we set out to solve a deeply personal problem for millions of Americans who had acute health conditions but were unable to access the medications they had been prescribed. We started by tackling affordability, not only to help alleviate patients’ financial hardships but also to equip thousands of providers and pharmacies with critical solutions to deliver care and strengthen their financial performance. We are thrilled to embark on this new chapter with GrowthCurve. They share our commitment to our mission, and they bring the experience and strategic support we need as we continue expanding our capabilities across the entire medication lifecycle.”
